Medicare Enrolled
Dr. Ilicia Shugarman, M.D.
Internal Medicine · Neptune Beach, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shugarman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shugarman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shugarman
Dr. Ilicia Shugarman is an internal medicine in Neptune Beach, FL, with 16 years in practice. Based on federal Medicare data, Dr. Shugarman performed 92,288 Medicare services across 3,137 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shugarman received a total of $4,164 from 57 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shugarman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 0% volume in FL$ $4,164 industry payments
Medicare Practice Summary
Medicare Utilization ↗92,288
Medicare services
Top 0% in FL for internal medicine
3,137
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,768 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 25,600 | $43 | $108 |
| Iron infusion (Injectafer) | 25,500 | $1 | $4 |
| Contrast dye for imaging (iodine-based) | 8,400 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 7,440 | $18 | $40 |
| Anti-nausea injection (fosaprepitant) | 6,150 | $0 | $5 |
| Iron sucrose injection (Venofer) | 3,600 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia | 3,500 | $6 | $27 |
| Complete blood count (CBC) with differential | 2,055 | $8 | $41 |
| Blood draw (venipuncture) | 1,974 | $8 | $18 |
| Dexamethasone injection (steroid) | 1,958 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 930 | $0 | $41 |
| Office visit, established patient (20-29 min) | 861 | $62 | $104 |
| Office visit, established patient (30-39 min) | 704 | $96 | $162 |
| Anti-nausea injection (Aloxi/palonosetron) | 700 | $1 | $75 |
| Administration of chemotherapy into vein, 1 hour or less | 413 | $97 | $355 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 403 | $22 | $90 |
| Drug injection, under skin or into muscle | 352 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 144 | $47 | $160 |
| Injection, zoledronic acid, 1 mg | 143 | $7 | $282 |
| Injection, diphenhydramine hcl, up to 50 mg | 105 | $1 | $4 |
| Hospital follow-up visit, moderate complexity | 100 | $62 | $115 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 96 | $1 | $7 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 91 | $70 | $70 |
| Administration of additional new drug or substance into vein, 1 hour or less | 90 | $49 | $175 |
| Administration of chemotherapy into vein, each additional hour | 88 | $22 | $80 |
| Injection of additional new drug or substance into vein | 87 | $12 | $55 |
| Infusion into a vein for hydration, each additional hour | 84 | $10 | $40 |
| Ct scan of chest with contrast | 74 | $46 | $500 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 71 | $15 | $45 |
| Infusion into a vein for hydration, 31-60 minutes | 61 | $24 | $130 |
| CT scan of abdomen and pelvis with contrast | 57 | $155 | $535 |
| Hospital follow-up visit, high complexity | 50 | $93 | $160 |
| Infusion, normal saline solution , 1000 cc | 44 | $2 | $97 |
| Initial hospital admission, moderate complexity | 43 | $101 | $225 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 41 | $401 | $1,000 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 40 | $1,090 | $2,400 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 34 | $1 | $21 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 32 | $66 | $153 |
| CT scan of chest, without contrast | 28 | $39 | $310 |
| New patient office visit (30-44 min) | 25 | $74 | $181 |
| New patient office visit, complex (60-74 min) | 25 | $168 | $340 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $24 | $84 |
| Office visit, established patient, complex (40-54 min) | 23 | $134 | $235 |
| Blood creatinine level | 19 | $5 | $29 |
| Initial hospital admission, high complexity | 17 | $137 | $330 |
| New patient office visit (45-59 min) | 12 | $131 | $265 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
28.5% high complexity
64.8% medium
6.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,164
Total received (2018-2024)
Avg $595/year across 7 years
Top 16% in FL for internal medicine
57
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,122 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$42 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$957
2023$535
2022$248
2021$280
2020$408
2019$930
2018$806
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$698
Janssen Biotech, Inc.
$541
PFIZER INC.
$519
Genentech USA, Inc.
$194
E.R. Squibb & Sons, L.L.C.
$185
Merck Sharp & Dohme Corporation
$180
Janssen Pharmaceuticals, Inc
$176
Daiichi Sankyo Inc.
$117
BeiGene USA, Inc.
$105
Foundation Medicine, Inc.
$102
GENZYME CORPORATION
$98
AstraZeneca Pharmaceuticals LP
$95
Amgen Inc.
$77
Alnylam Pharmaceuticals Inc.
$72
Incyte Corporation
$61
Celgene Corporation
$54
Lexicon Pharmaceuticals, Inc.
$51
Exelixis Inc.
$50
Karyopharm Therapeutics Inc.
$50
Acrotech Biopharma Inc.
$42
Taiho Oncology, Inc.
$37
GlaxoSmithKline, LLC.
$34
MEDIVATION FIELD SOLUTIONS LLC
$32
Takeda Pharmaceuticals U.S.A., Inc.
$32
ABBVIE INC.
$31
Gilead Sciences, Inc.
$30
Shield Therapeutics Inc
$27
Alexion Pharmaceuticals, Inc.
$27
Lilly USA, LLC
$26
MorphoSys, US Inc.
$25
Astellas Pharma US Inc
$24
Tempus AI, Inc
$22
Mirati Therapeutics, Inc.
$22
Octapharma USA, Inc.
$20
ARRAY BIOPHARMA INC
$20
ADC Therapeutics America, Inc.
$20
EUSA Pharma (US) LLC
$17
INSYS Therapeutics Inc
$16
Kyowa Kirin, Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Global Blood Therapeutics, Inc.
$15
SOBI, INC
$14
AMAG Pharmaceuticals, Inc.
$14
TG Therapeutics, Inc.
$13
Stemline Therapeutics Inc.
$13
EMD Serono, Inc.
$13
Secura Bio, Inc.
$12
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Eisai Inc.
$12
Aurobindo Pharma USA, Inc.
$12
Bayer HealthCare Pharmaceuticals Inc.
$11
Regeneron Healthcare Solutions, Inc.
$11
Pharmacyclics LLC, An AbbVie Company
$11
Puma Biotechnology, Inc.
$11
TESARO, Inc.
$11
Clovis Oncology, Inc.
$10
ADMA BioManufacturing LLC
$9
Top 3 companies account for 42.2% of total payments
Associated products mentioned in payments ›
ACCRUFER · AFINITOR · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELREXFIO · EMPLICITI · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Polivy · REBLOZYL · RYBREVANT · RYDAPT · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · SYNDROS · Sylvant · TAGRISSO · TASIGNA · TIVDAK · Tavalisse · Tecentriq · Trodelvy · UKONIQ · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Vanflyta · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $5 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
930
Per 100K population
92.3
County median income
$68,447
Nearest hospital
BAPTIST MEDICAL CENTER BEACHES
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Shugarman is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 16%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Shugarman experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Shugarman performed 25,600 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shugarman receive payments from pharmaceutical companies?
Yes. Dr. Shugarman received a total of $4,164 from 57 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shugarman's costs compare to other internal medicines in Neptune Beach?
Dr. Shugarman's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shugarman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Neptune Beach
Browse internal medicines in Neptune Beach ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in FL
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in FL
Which FL internal medicines receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology